- Home
- GNLX vs ALTS Comparison
GNLX vs ALTS Comparison
Compare GNLX & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- ALTS
- Stock Information
- Founded
- GNLX 2001
- ALTS 1976
- Country
- GNLX United States
- ALTS United States
- Employees
- GNLX N/A
- ALTS N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- GNLX Health Care
- ALTS
- Exchange
- GNLX Nasdaq
- ALTS NYSE
- Market Cap
- GNLX 112.8M
- ALTS 159.4M
- IPO Year
- GNLX 2023
- ALTS N/A
- Fundamental
- Price
- GNLX $3.09
- ALTS $7.85
- Analyst Decision
- GNLX Strong Buy
- ALTS
- Analyst Count
- GNLX 4
- ALTS 0
- Target Price
- GNLX $17.75
- ALTS N/A
- AVG Volume (30 Days)
- GNLX 137.5K
- ALTS 298.8K
- Earning Date
- GNLX 08-13-2025
- ALTS 08-18-2025
- Dividend Yield
- GNLX N/A
- ALTS N/A
- EPS Growth
- GNLX N/A
- ALTS N/A
- EPS
- GNLX N/A
- ALTS N/A
- Revenue
- GNLX N/A
- ALTS $18,046,000.00
- Revenue This Year
- GNLX N/A
- ALTS $185.91
- Revenue Next Year
- GNLX N/A
- ALTS $64.93
- P/E Ratio
- GNLX N/A
- ALTS N/A
- Revenue Growth
- GNLX N/A
- ALTS N/A
- 52 Week Low
- GNLX $1.60
- ALTS $1.29
- 52 Week High
- GNLX $5.89
- ALTS $10.95
- Technical
- Relative Strength Index (RSI)
- GNLX 56.10
- ALTS 47.87
- Support Level
- GNLX $2.75
- ALTS $6.62
- Resistance Level
- GNLX $3.17
- ALTS $10.38
- Average True Range (ATR)
- GNLX 0.24
- ALTS 1.04
- MACD
- GNLX -0.00
- ALTS -0.29
- Stochastic Oscillator
- GNLX 56.94
- ALTS 38.52
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.